-
SPECIAL ANNOUNCEMENT: This entire issue will be freely available until May 30, 2026 in celebration of the NKF Spring Clinical Meeting Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from [...]
-
The NephMadness Court of Champions is welcoming a 14th member: B-cell Modulators This year entries continued to reflect the general decline in social media popularity… … while international entries stayed pretty steady. As usual, NephMadness 2026 required the talent, effort, and time of an extensive team. These folks make it all possible! We’d like to take this opportunity to recognize their contributions (with apologies to anyone we may have inadvertently missed): Blue [...]
-
NephMadness 2026 is over, and as usual we saw our fair share of buzzer beaters, upsets, and Cinderella stories. Team B-cell Modulators from the IgA Nephropathy Region emerged from a crowded field as the new champion, and its ascendance was good news for our new set of winners! Grand Prizes Each Grand Prize individual winner will receive a one-year online subscription to Advances in Kidney Disease and Health and Nature Reviews Nephrology. TOP OVERALL SCORE: Santiago Moreno Tobón Dr Moreno [...]
-
It’s all been building to this; the Blue Ribbon Panel has decreed a new NephMadness champion for 2026! Check out the Final Standings and share your reactions with #NephMadness! Many thanks to Krithika Mohan @krithicism for the scoreboard graphics! Team C3G Treatment had a magical run, but finally ran out of steam. Team B-cell Modulators’ strong offense dominated the final match up. Team B-cell Modulator with the easy win. B-cell Modulators wins 7-2 Comments from the BRP: [...]
-
Song Ong @SongOngUAB Song Ong is a professor at the University of Alabama at Birmingham. He is a transplant nephrologist and remains humbled by the fearful and wonderful complexity of the human immune system. Dana Rizk Dana Rizk is Tenured Professor in the Division of Nephrology and Associate Dean for Clinical Trials at the University of Alabama at Birmingham Heersink School of Medicine. Her research interest focuses on IgA Nephropathy and she has ~100 peer-reviewed publications in [...]
Follow Blog by Email:
NephMadness 2026
-
NephMadness#NephMadness 2026: C3G Region
-
NephMadness#NephMadness 2026: Blue Ribbon Panel
-
NephMadness#NephMadness 2026: The Left and Right Kidneys
-
NephMadness#NephMadness 2026: The PodCrawl
-
NephMadness#NephMadness 2026: Genetics – May the Best Gene Win
-
NephMadness#NephMadness 2026: POCUS – Stop Guessing, Start Scanning
-
NephMadness#NephMadness 2026: POCUS Region
-
NephMadness#NephMadness 2026: Trolls of Transplantation Region
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIRenal Amyloidosis – What We Need to Consider, Practical Tips
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 3
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology II: The Ultimate Pathology Teaching Tool Has Arrived
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Light Chain Cast Nephropathy
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 1
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology IICongenital Nephrotic Syndrome: Finnish Type or Diffuse Mesangial Sclerosis?
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 2
-
Atlas of Renal Pathology IIPractical Tips for the Diagnosis of Acute Antibody-Mediated Rejection
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy







